GIANT BIOGENE(02367)
Search documents
巨子股价跌超15%,可复美双十一首战GMV同比下跌8%
2 1 Shi Ji Jing Ji Bao Dao· 2025-10-16 10:07
Group 1 - The core viewpoint indicates that the ongoing impact of the competitive landscape is affecting the performance of the company, with a significant drop in stock price and sales figures [2] - The company's main brand, 可复美, experienced a decline in sales during the first half of October, with a total GMV of 65.89 million yuan from October 1 to October 14, reflecting a year-on-year decrease of 8% [2] - Specifically, the GMV from October 1 to October 8 was 20.58 million yuan, down 16% year-on-year, while from October 9 to October 14, it was 45.40 million yuan, down 4% year-on-year [2] Group 2 - The product in question, the collagen stick from the 可复美 brand, has been previously involved in a controversy regarding its ingredients [3] - Another main brand of the company, 可丽金, showed a slight recovery in GMV during the same period, indicating some positive performance amidst the challenges faced by 可复美 [4]
北水动向|北水成交净买入158.22亿 紫金黄金国际(02259)正式入通 北水全天抢筹超17亿港元
智通财经网· 2025-10-16 10:00
Core Insights - The Hong Kong stock market saw a net inflow of 15.822 billion HKD from northbound trading on October 16, with the Shanghai-Hong Kong Stock Connect contributing 8.672 billion HKD and the Shenzhen-Hong Kong Stock Connect contributing 7.15 billion HKD [1] Group 1: Stock Performance - The most net bought stocks included Zijin Mining International (02259), Xiaomi Group-W (01810), and Alibaba-W (09988) [1] - The most net sold stocks included SMIC (00981), GigaDevice Semiconductor (02367), and Tencent (00700) [1] Group 2: Detailed Stock Transactions - Alibaba-W had a net inflow of 2.696 billion HKD, with total transactions amounting to 4.816 billion HKD [2] - Xiaomi Group-W recorded a net inflow of 2.508 billion HKD, with total transactions of 3.995 billion HKD [2] - SMIC had a net outflow of 539.09 million HKD, with total transactions of 3.5 billion HKD [2] - Tencent experienced a net outflow of 235 million HKD, with total transactions of 3.02 billion HKD [2] - Zijin Mining International received a net inflow of 1.738 billion HKD, following its inclusion in the Stock Connect list [4] Group 3: Company-Specific News - Zijin Mining International is expected to achieve a compound annual growth rate of approximately 20% in production from 2025 to 2027, increasing total output from 45 tons to 65 tons, leading to a 30% compound annual growth rate in profits [4] - Xiaomi Group's stock price has been volatile due to various news events, with expectations of a decline in gross profit margin in the second half of the year [5] - Alibaba's stock received a boost from the launch of the Tmall Double 11 shopping festival and an upgrade in capital expenditure forecasts by Goldman Sachs [5] - Kangfang Biopharma (09926) received a net inflow of 6.02 billion HKD following the acceptance of its clinical research results for a new drug in a top medical journal [6] - Pop Mart (09992) saw a net inflow of 4.7 billion HKD, with expectations of strong sales growth from new IPs [7]
巨子生物获控股股东Juzi Holding增持76万股公司股份
Zhi Tong Cai Jing· 2025-10-16 09:57
巨子生物(02367)发布公告,公司董事会接获公司控股股东Juzi Holding Co.,Ltd通知,基于对公司未来发 展的强烈信心,为促进公司持续、稳定、健康发展,维护广大公众投资者利益,于本公告日期,Juzi Holding于市场内合共购入76万股公司股份,本次增持金额合计约为3190万港元(不包括佣金及其他开 支)。紧随本次增持后,于本公告日期,Juzi Holding合共持有公司5.84亿股股份,占公司已发行总股数 的54.56%。Juzi Holding可能会根据市场状况和适用的监管要求,不时进一步增持公司股份。 ...
巨子生物(02367.HK)获控股股东以3190万港元增持76万股
Ge Long Hui· 2025-10-16 09:56
Core Viewpoint - Juzi Holding, the controlling shareholder of Juzi Bio (02367.HK), has purchased 760,000 shares of the company, amounting to approximately HKD 31.9 million, to support the company's future development and protect public investors' interests [1] Group 1 - Juzi Holding's total shareholding after the purchase is 584,271,535 shares, representing 54.56% of the company's total issued shares [1] - The company may consider further share purchases depending on market conditions and regulatory requirements [1]
巨子生物(02367) - 自愿性公告 控股股东增持股份
2025-10-16 09:46
自願性公告 控股股東增持股份 本公告乃由巨子生物控股有限公司(「本公司」)自 願 作 出。兹 提 述 本 公 司 日 期 為 2025年6月9日 的 公 告,內 容 有 關 控 股 股 東 增 持 本 公 司 股 份 的 計 劃。 (於 開 曼 群 島 註 冊 成 立 的 獲 豁 免 有 限 公 司) (股 份 代 號:2367) GIANT BIOGENE HOLDING CO., LTD 巨子生物控股有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 嚴建亞 中 國 西 安,2025年10月16日 截至本公告日期,董事會成員包括執行董事嚴建亞先生、葉娟女士、方娟女士、 張 慧 娟 女 士 及 嚴 鈺 博 女 士 以 及 獨 立 非 執 行 董 事 黃 進 先 生、單 文 華 先 生 及 黃 斯 穎 女 士。 本 公 司 股 東 及 有 意 投 資 者 於 買 賣 本 公 司 股 份 時 ...
智通港股52周新高、新低统计|10月16日





智通财经网· 2025-10-16 08:46
Summary of Key Points Core Viewpoint - As of October 16, a total of 69 stocks reached their 52-week highs, indicating a positive trend in the market, with notable performances from companies like Jinglian Group, Century United Holdings, and Huisi Pacific. Group 1: Stocks Reaching 52-Week Highs - Jinglian Group (01751) achieved a closing price of 0.890 with a peak of 1.130, marking a high increase rate of 34.52% [1] - Century United Holdings (01959) closed at 0.750, reaching a high of 0.900, with a growth rate of 20.00% [1] - Huisi Pacific (08147) had a closing price of 0.970 and a peak of 0.980, reflecting a 13.95% increase [1] - Other notable stocks include Xiangxing International (01732) with a 13.46% increase and Puleshi Group Holdings (02486) with a 12.06% increase [1] Group 2: Stocks Reaching 52-Week Lows - Jixin Guokong (08629) saw a significant decline, closing at 6.450 with a low of 5.150, resulting in a drop of 35.63% [2] - Qizhan Holdings (01808) closed at 2.990, hitting a low of 2.400, reflecting a decrease of 16.67% [2] - Kun Group (00924) reached a low of 0.184, closing at 0.185, with a decline of 16.36% [2] - Other companies experiencing declines include Hongyang Services (01971) with a 9.82% drop and Xuan Bamboo Biotechnology (02575) with a 9.43% decrease [2]
走完可丽金“重组”第三站,我与世界和解了
FBeauty未来迹· 2025-10-15 12:21
Core Viewpoint - The article emphasizes the importance of mental health awareness and the integration of emotional well-being with skincare, highlighting the brand's initiative to promote a philosophy of "self-pleasure" through its activities and products [4][31]. Group 1: Brand Philosophy and Initiatives - The concept of "self-pleasure" has become a prevalent lifestyle choice, with the brand keenly observing user emotions and relationships to integrate social responsibility into its offerings [4][6]. - The brand's narrative revolves around "restructuring" relationships, which not only pertains to skincare but also to emotional and relational reconnections [6][12]. - The brand's core components include the C5HA recombinant collagen protein, which is scientifically formulated to enhance skin health while also addressing deeper emotional connections [7][8]. Group 2: Emotional Engagement and Activities - The brand's "self-pleasure" series of activities progresses through three phases: identity restructuring, energy restructuring, and relationship restructuring, reflecting the evolving psychological trends in society [9][11]. - The activities are designed to create a deeper emotional connection, transforming skincare routines into meaningful rituals that promote self-dialogue and emotional release [12][27]. - The brand collaborates with various organizations to raise awareness about mental health issues, including a partnership with a foundation to showcase artworks from individuals with depression, emphasizing the importance of emotional expression [24][25]. Group 3: Social Responsibility and Community Impact - The brand's initiatives extend beyond product promotion to include community engagement and emotional support, aiming to foster a more inclusive environment for mental health discussions [34][36]. - The company has implemented internal programs focused on emotional care, reinforcing its commitment to mental health awareness within its corporate culture [36]. - The brand's efforts to integrate social responsibility into its core operations demonstrate a commitment to addressing broader societal challenges related to mental health [34][37].
巨子生物逆势跌超4%创9个月新低 市场关注双十一可复美销情
Zhi Tong Cai Jing· 2025-10-15 04:42
Core Viewpoint - The stock of Giant Bio (02367) has declined over 4%, reaching a new low of 47.92 HKD since January, with a current price of 48.1 HKD and a trading volume of 4.57 billion HKD [1] Group 1: Market Performance - The stock price of Giant Bio has dropped by 4.09% [1] - The trading volume for the stock is reported at 4.57 billion HKD [1] Group 2: Industry Trends - The "Double 11" shopping festival for 2025 is approaching, with a focus on cosmetics experiencing a seasonal slowdown in Q3 according to Zheshang Securities [1] - Data from Chan Mama indicates that the growth rate of key brands on Douyin has weakened in Q3, with Giant Bio's GMV increasing by 15% year-on-year, while its sub-brands, Kefu Mei and Keli Jin, saw increases of 5% and 78% respectively [1] Group 3: Company Developments - Giant Bio is focusing on the upcoming "Double 11" sales push in the second half of the year [1] - There are ongoing issues regarding the recombinant collagen products of Kefu Mei, with Huaxi Bio reporting that multiple third-party testing results show the recombinant collagen content does not meet standards, and these reports have been submitted to the National Medical Products Administration [1]
港股异动 | 巨子生物(02367)逆势跌超4%创9个月新低 市场关注双十一可复美销情
智通财经网· 2025-10-15 04:04
Group 1 - The stock of Giant Bio (02367) has fallen over 4%, reaching a new low of 47.92 HKD since January this year, with a trading volume of 4.57 billion HKD [1] - According to Zheshang Securities, the cosmetics industry is experiencing a weak Q3, with some key brands showing a decline in growth on Douyin [1] - Giant Bio's GMV on Douyin increased by 15% year-on-year in Q3, with specific brands like Kefu Mei growing by 5% and Keli Jin by 78% [1] Group 2 - The company is focusing on the upcoming Double Eleven sales event in the second half of the year [1] - There are ongoing issues regarding the recombinant collagen products of Kefu Mei, with Huaxi Bio reporting that several third-party testing results indicate that the collagen content does not meet standards [1] - Huaxi Bio has submitted dozens of test reports to the National Medical Products Administration [1]
中金:内地黄金周年轻人成消费主力悦己消费长期布局 推荐潮玩及电子烟等板块
Zhi Tong Cai Jing· 2025-10-13 08:26
Core Insights - The report from CICC indicates that the consumption data for the National Day and Mid-Autumn Festival holidays in 2025 shows strong performance, driven by longer holiday periods and a high level of domestic and outbound travel [1] Group 1: Consumption Trends - Overall consumption data reflects a youthful and experience-oriented trend, with notable performance in discretionary categories such as home appliances and outdoor sports [1] - The average daily flow of cross-regional personnel in mainland China from October 1 to 8 increased by 6.2% year-on-year, indicating a robust travel environment [1] - The average spending per trip during the holiday increased by 14.6% year-on-year, attributed to the ongoing recovery of outbound tourism and a rise in long-distance and segmented travel within the country [1] Group 2: Retail Performance - The Ministry of Commerce's monitoring of 78 key business districts showed a year-on-year increase in foot traffic and sales of 4.2% and 4% respectively during the first three days of the holiday [1] - Data from the National Immigration Administration revealed that the average daily number of inbound and outbound travelers exceeded 2 million, marking a 15% year-on-year increase [1] Group 3: Investment Recommendations - CICC recommends focusing on sectors benefiting from self-indulgent consumption trends, such as trendy toys and e-cigarettes, highlighting companies like Pop Mart (09992), Blucor (00325), and Smoore International (06969) [1] - The report also suggests investing in domestic brands in the beauty and personal care sectors, recommending companies like Mao Geping (01318), Giant Bio (02367), and Shanghai Jahwa (600315) [1] - Attention is drawn to retail sectors that may benefit from supportive domestic policies and seasonal catalysts [1]